Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (161-170 of 563) with videos related to

Pageof 57
Sort By:
The Journal of Biological Chemistry|December 16, 1998
Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptaseH Pelemans, R M Esnouf, H Jonckheere, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependentJ Balzarini, E Matthes, P Meeus, et al.
Journal of Medicinal Chemistry|April 1, 1986
Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triestersJ Bères, W G Bentrude, J Balzarini, et al.
Journal of Medicinal Chemistry|March 1, 1987
Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycinE De Clercq, J Balzarini, D Madej, et al.
Journal of Medicinal Chemistry|August 1, 1989
3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analoguesA Van Aerschot, P Herdewijn, J Balzarini, et al.
The Journal of Biological Chemistry|August 14, 1999
Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogasterM Johansson, A R van Rompay, B Degrève, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitorsJ Balzarini, H Pelemans, A Karlsson, et al.
The Biochemical Journal|May 1, 1983
Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridineE De Clercq, J Descamps, J Balzarini, et al.
Journal of Medicinal Chemistry|January 1, 1989
Synthesis and cytostatic and antiviral activities of 1-beta-D-ribofuranosyl-5-alkylcytosine (5-alkylcytidine) cyclic 3',5'-monophosphatesJ Béres, W G Bentrude, L Otvös, et al.
FEBS Letters|July 4, 1988
AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous systemP F Torrence, J Kinjo, K Lesiak, et al.
Pageof 57

Showing results (161-170 of 563) with videos related to

Sort By:
Pageof 57
The Journal of Biological Chemistry|December 16, 1998
Mutational analysis of Tyr-318 within the non-nucleoside reverse transcriptase inhibitor binding pocket of human immunodeficiency virus type I reverse transcriptaseH Pelemans, R M Esnouf, H Jonckheere, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
The antiretroviral and cytostatic activity, and metabolism of 3'-azido-2',3'-dideoxythymidine, 3'-fluoro-2',3'-dideoxythymidine and 2',3'-dideoxycytidine are highly cell type-dependentJ Balzarini, E Matthes, P Meeus, et al.
Journal of Medicinal Chemistry|April 1, 1986
Synthesis and antitumor and antiviral properties of 5-alkyl-2'-deoxyuridines, 3',5'-cyclic monophosphates, and neutral cyclic triestersJ Bères, W G Bentrude, J Balzarini, et al.
Journal of Medicinal Chemistry|March 1, 1987
Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycinE De Clercq, J Balzarini, D Madej, et al.
Journal of Medicinal Chemistry|August 1, 1989
3'-Fluoro-2',3'-dideoxy-5-chlorouridine: most selective anti-HIV-1 agent among a series of new 2'- and 3'-fluorinated 2',3'-dideoxynucleoside analoguesA Van Aerschot, P Herdewijn, J Balzarini, et al.
The Journal of Biological Chemistry|August 14, 1999
Cloning and characterization of the multisubstrate deoxyribonucleoside kinase of Drosophila melanogasterM Johansson, A R van Rompay, B Degrève, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
Concomitant combination therapy for HIV infection preferable over sequential therapy with 3TC and non-nucleoside reverse transcriptase inhibitorsJ Balzarini, H Pelemans, A Karlsson, et al.
The Biochemical Journal|May 1, 1983
Antiviral activity of the 3'-amino derivative of (E)-5-(2-bromovinyl)-2'-deoxyuridineE De Clercq, J Descamps, J Balzarini, et al.
Journal of Medicinal Chemistry|January 1, 1989
Synthesis and cytostatic and antiviral activities of 1-beta-D-ribofuranosyl-5-alkylcytosine (5-alkylcytidine) cyclic 3',5'-monophosphatesJ Béres, W G Bentrude, L Otvös, et al.
FEBS Letters|July 4, 1988
AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous systemP F Torrence, J Kinjo, K Lesiak, et al.
Pageof 57